Viking Therapeutics

frozen cold viking long boat winter snow
Biotech

Viking hits stormy seas as phase 2 oral obesity data sink stock

Viking saw weight loss of up to 12.2%. But with 38% of patients discontinuing treatment at the most effective dose, investors sent the stock down 37%.
Nick Paul Taylor Aug 19, 2025 9:44am
Liver disease

Viking liver disease drug reduces fibrosis in final ph. 2 data

Nov 20, 2024 3:20pm
viking ship long boat chase race water sunset

Viking oral obesity med posts 6.8% weight loss for highest dose

Nov 4, 2024 7:30am
ship flagship sail ocean boats

Viking to charge quickly into phase 3 with obesity med

Jul 25, 2024 9:19am
leg up help pull climb assist teamwork

Pfizer's obesity pill news leaves analysts wanting

Jul 12, 2024 10:17am
weight loss scale weigh measure tape obesity overweight

Terns' ex-MASH drug cuts fat, not muscle in GLP-1 combo in mice

Jun 25, 2024 8:51am